SEARCH

SEARCH BY CITATION

References

  • 1
    De Leon DD, Stanley CA. Mechanisms of disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab 2007; 3: 5768.
  • 2
    James C, Kapoor RR, Ismail D, Hussain K. The genetic basis of congenital hyperinsulinism. J Med Genet 2009; 46: 289299.
  • 3
    Kapoor RR, Flanagan SE, James C, Shield J, Ellard S, Hussain K. Hyperinsulinaemic hypoglycaemia. Arch Dis Child 2009; 94: 450457.
  • 4
    Bruun MF, Christoffersen SH, Brusgaard K, Detlefsen S, Christesen HT. Congenital hyperinsulinism—new causes and clinical variations. Ugeskr Laeger 2011; 173: 30263031. Review. Dannish.
  • 5
    Banerjee I, Skae M, Flanagan SE, Rigby L, Patel L, Didi M, et al. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism. Eur J Endocrinol 2011; 164: 733740.
  • 6
    Flanagan SE, Kapoor RR, Hussain K. Genetics of congenital hyperinsulinemic hypoglycemia. Semin Pediatr Surg 2011; 20: 1317.
  • 7
    Kapoor RR, Locke J, Colclough K, Wales J, Conn JJ, Hattersley AT, et al. Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations. Diabetes 2008; 57: 16591663.
  • 8
    Kyithar MP, Bacon S, Pannu KK, Rizvi SR, Colclough K, Ellard S, et al. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications. Diabetes Metab 2011; 37: 512519.
  • 9
    Pearson ER, Boj SF, Steele AM, Barrett T, Stals K, Shield JP, et al. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med 2007; 4: e118.
  • 10
    Flanagan SE, Kapoor RR, Mali G, Cody D, Murphy N, Schwahn B, et al. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. Eur J Endocrinol 2010; 162: 987992.
  • 11
    Stanescu DE, Hughes N, Kaplan B, Stanley CA, De Leon DD. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab 2012; 97: E20262030.
  • 12
    Fajans SS, Bell GI. Macrosomia and neonatal hypoglycaemia in RW pedigree subjects with a mutation (Q268X) in the gene encoding hepatocyte nuclear factor 4alpha (HNF4A). Diabetologia 2007; 50: 26002601.
  • 13
    Ellard S, Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Hum Mutat 2006; 27: 854869.
  • 14
    Huang T, Kelly A. Hypertrophic cardiomyopathy in neonates with congenital hyperinsulinism. Arch Dis Child Fetal Neonatal Ed 2013; 98: F351F354.
  • 15
    Shield J, Scharfmann R. Development of the pancreas and neonatal diabetes. Endocr Dev 2007; 12: 3345.
  • 16
    Gupta RK, Vatamaniuk M. The MODY1 gene HNF4α regulates selected genes involved in insulin secretion. J Clin Invest 2005; 115: 10061015.
  • 17
    Miura A, Yamagata K. Hepatocyte nuclear factor 4-alpha is essential for glucose-stimunlated insulin secretion by pancreatic beta-cells. J Biol Chem 2006; 281: 52465257.
  • 18
    Boj SF, Parrizas M. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc Natl Acad Sci U S A 2001; 98: 1448114486.
  • 19
    Yamagata K, Furata H. Mutations in the hepatocyte nuclear factor 4-alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996; 384: 458460.
  • 20
    Byrne MM, Sturis J. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes 1995; 44: 699704.